A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma. (Q33785079)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Hylke de Jonge

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kristin Verbeke

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yves Vanrenterghem

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

29 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Biomedical Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1091-1098

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography-negative chemical ionization-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Determination of midazolam in human plasma by solid-phase microextraction and gas chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Cytochrome P-450 3A4: regulation and role in drug metabolism

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Simultaneous determination of midazolam and 1'-hydroxymidazolam in human plasma by liquid chromatography with tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Simultaneous determination of levomepromazine, midazolam and their major metabolites in human plasma by reversed-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe.

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity

1 reference

https://api.crossref.org/works/10.1002%2FBMC.1576

21 January 2018

Identifiers

10.1002/BMC.1576

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21204116%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33785079&oldid=2144584987"